Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04157751
Recruitment Status : Completed
First Posted : November 8, 2019
Last Update Posted : July 7, 2021
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 28, 2021
Actual Study Completion Date : June 2, 2021